FDA.reportPublic FDA data

selpercatinib 40 MG Oral Tablet

RxCUI
2679813
RxNorm name
selpercatinib 40 MG Oral Tablet
Display name
selpercatinib 40 MG Oral Tablet
Full name
selpercatinib 40 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7fa848ba-a59c-4144-9f52-64d090f4d828selpercatinib 40 MG Oral Tablet [PSN] · selpercatinib 40 MG Oral Tablet [SCD] · selpercatinib 40 MG Oral Tablet [SY]322These highlights do not include all the information needed to use RETEVMO safely and effectively. See full prescribing information for RETEVMO. RETEVMO ® (selpercatinib) capsules, for oral use RETEVMO ® (selpercatinib) tablets, for oral use Initial U.S. Approval: 202020251120